Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study
Crossref DOI link: https://doi.org/10.1007/s00774-017-0839-2
Published Online: 2017-04-07
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hagino, Hiroshi
Ito, Masako
Hashimoto, Junko
Yamamoto, Masao
Endo, Koichi
Katsumata, Kyoko
Asao, Yoshihiro
Matsumoto, Rumiko
Nakano, Tetsuo
Mizunuma, Hideki
Nakamura, Toshitaka
License valid from 2017-04-07